
NHS England agrees deal for gene therapy for spinal muscular atrophy
NHS England has agreed a deal to ensure that Zolgensma (onasemnogene abeparvovec), a one-off gene…

NHS England has agreed a deal to ensure that Zolgensma (onasemnogene abeparvovec), a one-off gene…